BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38169715)

  • 21. Synthetic growth hormone-releasing hormone agonist ameliorates the myocardial pathophysiology characteristic of heart failure with preserved ejection fraction.
    Dulce RA; Kanashiro-Takeuchi RM; Takeuchi LM; Salerno AG; Wanschel ACBA; Kulandavelu S; Balkan W; Zuttion MSSR; Cai R; Schally AV; Hare JM
    Cardiovasc Res; 2023 Feb; 118(18):3586-3601. PubMed ID: 35704032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of brain angiotensin III attenuates sympathetic hyperactivity and cardiac dysfunction in rats post-myocardial infarction.
    Huang BS; Ahmad M; White RA; Marc Y; Llorens-Cortes C; Leenen FH
    Cardiovasc Res; 2013 Mar; 97(3):424-31. PubMed ID: 23257024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel pathomechanisms of cardiomyocyte dysfunction in a model of heart failure with preserved ejection fraction.
    Primessnig U; Schönleitner P; Höll A; Pfeiffer S; Bracic T; Rau T; Kapl M; Stojakovic T; Glasnov T; Leineweber K; Wakula P; Antoons G; Pieske B; Heinzel FR
    Eur J Heart Fail; 2016 Aug; 18(8):987-97. PubMed ID: 27135883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
    J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac sympathetic overdrive, M2 macrophage activation and fibroblast heterogeneity are associated with cardiac remodeling in a chronic pressure overload rat model of HFpEF.
    Sun F; Yuan L; Wang Z; Cui X; Lv N; Zhang T; Zhang Y; Cai J
    Front Pharmacol; 2024; 15():1364758. PubMed ID: 38860171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential role of TIMP2 and TIMP3 in cardiac hypertrophy, fibrosis, and diastolic dysfunction.
    Fan D; Takawale A; Basu R; Patel V; Lee J; Kandalam V; Wang X; Oudit GY; Kassiri Z
    Cardiovasc Res; 2014 Jul; 103(2):268-80. PubMed ID: 24692173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Canagliflozin Ameliorates Ventricular Remodeling through Apelin/Angiotensin-Converting Enzyme 2 Signaling in Heart Failure with Preserved Ejection Fraction Rats.
    Zhang T; Wang X; Wang Z; Zhai J; He L; Wang Y; Zuo Q; Ma S; Zhang G; Guo Y
    Pharmacology; 2023; 108(5):478-491. PubMed ID: 37611563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Preclinical Rat Model of Heart Failure With Preserved Ejection Fraction With Multiple Comorbidities.
    Hubesch G; Hanthazi A; Acheampong A; Chomette L; Lasolle H; Hupkens E; Jespers P; Vegh G; Wembonyama CWM; Verhoeven C; Dewachter C; Vachiery JL; Entee KM; Dewachter L
    Front Cardiovasc Med; 2021; 8():809885. PubMed ID: 35097026
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Kamiya M; Asai K; Maejima Y; Shirakabe A; Murai K; Noma S; Komiyama H; Sato N; Mizuno K; Shimizu W
    J Pharmacol Exp Ther; 2021 Mar; 376(3):473-481. PubMed ID: 33318077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knockout of MD1 contributes to sympathetic hyperactivity and exacerbates ventricular arrhythmias following heart failure with preserved ejection fraction via NLRP3 inflammasome activation.
    Yang HJ; Kong B; Shuai W; Zhang JJ; Huang H
    Exp Physiol; 2020 Jun; 105(6):966-978. PubMed ID: 32240565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combining three independent pathological stressors induces a heart failure with preserved ejection fraction phenotype.
    Li Y; Kubo H; Yu D; Yang Y; Johnson JP; Eaton DM; Berretta RM; Foster M; McKinsey TA; Yu J; Elrod JW; Chen X; Houser SR
    Am J Physiol Heart Circ Physiol; 2023 Apr; 324(4):H443-H460. PubMed ID: 36763506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation Between Liver Stiffness and Diastolic Function, Left Ventricular Hypertrophy, and Right Cardiac Function in Patients With Ejection Fraction Preserved Heart Failure.
    Zhang J; Xu M; Chen T; Zhou Y
    Front Cardiovasc Med; 2021; 8():748173. PubMed ID: 34901210
    [No Abstract]   [Full Text] [Related]  

  • 33. Adenine-Induced Chronic Renal Failure in Rats: A Model of Chronic Renocardiac Syndrome with Left Ventricular Diastolic Dysfunction but Preserved Ejection Fraction.
    Kashioulis P; Lundgren J; Shubbar E; Nguy L; Saeed A; Guron CW; Guron G
    Kidney Blood Press Res; 2018; 43(4):1053-1064. PubMed ID: 29969785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early onset of chondroitin sulfate and osteopontin expression in angiotensin II-dependent left ventricular hypertrophy.
    Rothermund L; Kreutz R; Kossmehl P; Fredersdorf S; Shakibaei M; Schulze-Tanzil G; Paul M; Grimm D
    Am J Hypertens; 2002 Jul; 15(7 Pt 1):644-52. PubMed ID: 12118914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual Endothelin-A/Endothelin-B Receptor Blockade and Cardiac Remodeling in Heart Failure With Preserved Ejection Fraction.
    Valero-Munoz M; Li S; Wilson RM; Boldbaatar B; Iglarz M; Sam F
    Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 27810862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Central infusion of aldosterone synthase inhibitor attenuates left ventricular dysfunction and remodelling in rats after myocardial infarction.
    Huang BS; White RA; Ahmad M; Tan J; Jeng AY; Leenen FH
    Cardiovasc Res; 2009 Feb; 81(3):574-81. PubMed ID: 18689429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Phenotypes of Heart Failure With Preserved Ejection Fraction to Select Preclinical Animal Models.
    van Ham WB; Kessler EL; Oerlemans MIFJ; Handoko ML; Sluijter JPG; van Veen TAB; den Ruijter HM; de Jager SCA
    JACC Basic Transl Sci; 2022 Aug; 7(8):844-857. PubMed ID: 36061340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Etiology-Dependent Impairment of Diastolic Cardiomyocyte Calcium Homeostasis in Heart Failure With Preserved Ejection Fraction.
    Frisk M; Le C; Shen X; Røe ÅT; Hou Y; Manfra O; Silva GJJ; van Hout I; Norden ES; Aronsen JM; Laasmaa M; Espe EKS; Zouein FA; Lambert RR; Dahl CP; Sjaastad I; Lunde IG; Coffey S; Cataliotti A; Gullestad L; Tønnessen T; Jones PP; Altara R; Louch WE
    J Am Coll Cardiol; 2021 Feb; 77(4):405-419. PubMed ID: 33509397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-level transcutaneous vagus nerve stimulation attenuates cardiac remodelling in a rat model of heart failure with preserved ejection fraction.
    Zhou L; Filiberti A; Humphrey MB; Fleming CD; Scherlag BJ; Po SS; Stavrakis S
    Exp Physiol; 2019 Jan; 104(1):28-38. PubMed ID: 30398289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of elevated left ventricular end diastolic pressure in patients with preserved ejection fraction using cardiac magnetic resonance.
    Gao C; Tao Y; Pan J; Shen C; Zhang J; Xia Z; Wan Q; Wu H; Gao Y; Shen H; Lu Z; Wei M
    Eur Radiol; 2019 May; 29(5):2360-2368. PubMed ID: 30631923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.